🇺🇸 FDA
Pipeline program

Vincristine Sulfate Liposome

LUYESIKE-VSL-Ⅲ-01

Phase 3 small_molecule active

Quick answer

Vincristine Sulfate Liposome for Adult Acute Lymphoblastic Leukemia is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Adult Acute Lymphoblastic Leukemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials